Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$26.74 - $40.81 $1,550 - $2,366
58 New
58 $1,000
Q2 2023

Jul 18, 2023

BUY
$28.52 - $40.7 $1.09 Million - $1.56 Million
38,312 Added 60.8%
101,322 $3.75 Million
Q1 2023

Apr 13, 2023

BUY
$29.39 - $36.27 $1.8 Million - $2.23 Million
61,402 Added 3818.53%
63,010 $1.97 Million
Q4 2022

Jan 23, 2023

SELL
$29.23 - $40.28 $53,520 - $73,752
-1,831 Reduced 53.24%
1,608 $0
Q3 2022

Oct 26, 2022

SELL
$37.92 - $63.74 $7,508 - $12,620
-198 Reduced 5.44%
3,439 $131,000
Q2 2022

Jul 25, 2022

SELL
$47.98 - $62.75 $480,951 - $629,006
-10,024 Reduced 73.38%
3,637 $198,000
Q1 2022

May 02, 2022

BUY
$49.85 - $96.11 $8,324 - $16,050
167 Added 1.24%
13,661 $852,000
Q4 2021

Jan 28, 2022

BUY
$77.3 - $105.0 $1.04 Million - $1.42 Million
13,494 New
13,494 $1.36 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.